Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy
By: Colorado BioScience Association Date: 04/27/2018
Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...
Learn MorePrescription Drugs: Just the Facts
By: Colorado BioScience Association Date: 04/20/2018
As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription...
Learn MoreWeekly Policy Update: Action on Two Bills and Advocacy in DC
By: Colorado BioScience Association Date: 04/20/2018
UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...
Learn MoreColorado BioScience Association Names New Board Members
By: Colorado BioScience Association Date: 04/20/2018
Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board...
Learn MoreDriving Down Drug Costs
By: Colorado BioScience Association Date: 04/16/2018
Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their f...
Learn MoreWeekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs
By: Colorado BioScience Association Date: 04/13/2018
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...
Learn MoreWeekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!
By: Colorado BioScience Association Date: 04/06/2018
Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...
Learn MoreUnderstanding Bills at the Legislature
By: Colorado BioScience Association Date: 04/02/2018
Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering...
Learn MoreWeekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update
By: Colorado BioScience Association Date: 03/30/2018
CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...
Learn MoreHow do drug companies determine prices?
By: Colorado BioScience Association Date: 03/26/2018
The Value of Innovation When you stop in to the pharmacy to pick up a prescription, you may wonder how manufacturers determine the price you pay. You may think the drug maker maintains full control ov...
Learn More